• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The efficacy of off-label IL-5-modulating treatment in rare eosinophil-mediated diseases.

作者信息

Shamriz Oded, Hershko Alon Y, Talmon Aviv, Ribak Yaarit, Elazary Anat Scheiman, Horev Liran, NaserEddin Adeeb, Neuman Tzahi, Shabat Sheer, Zlotogorski Abraham, Tal Yuval

机构信息

Allergy and Clinical Immunology Unit, Department of Medicine, Jerusalem, Israel; The Lautenberg Center for Immunology and Cancer Research, Institute of Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel.

Allergy and Clinical Immunology Unit, Department of Medicine, Jerusalem, Israel.

出版信息

Allergol Int. 2021 Apr;70(2):266-268. doi: 10.1016/j.alit.2020.10.001. Epub 2020 Oct 21.

DOI:10.1016/j.alit.2020.10.001
PMID:33779559
Abstract
摘要

相似文献

1
The efficacy of off-label IL-5-modulating treatment in rare eosinophil-mediated diseases.标签外使用白细胞介素-5调节疗法在罕见嗜酸性粒细胞介导疾病中的疗效。
Allergol Int. 2021 Apr;70(2):266-268. doi: 10.1016/j.alit.2020.10.001. Epub 2020 Oct 21.
2
The role of interleukin 5 in asthma.白细胞介素5在哮喘中的作用。
Expert Rev Clin Immunol. 2016 Sep;12(9):903-5. doi: 10.1080/1744666X.2016.1208564. Epub 2016 Jul 25.
3
Improved small airway dysfunction in severe asthma with clinical remission by anti-interleukin-5/interleukin-5 receptor α.抗白细胞介素-5/白细胞介素-5受体α治疗使重度哮喘临床缓解伴小气道功能障碍改善
Ann Allergy Asthma Immunol. 2024 May;132(5):648-650. doi: 10.1016/j.anai.2024.02.006. Epub 2024 Feb 13.
4
Engineering of Humanized Antibodies Against Human Interleukin 5 Receptor Alpha Subunit That Cause Potent Antibody-Dependent Cell-Mediated Cytotoxicity.针对人白细胞介素 5 受体α亚基的人源化抗体的工程改造，导致了有效的抗体依赖性细胞介导的细胞毒性。
Front Immunol. 2021 Jan 8;11:593748. doi: 10.3389/fimmu.2020.593748. eCollection 2020.
5
Reslizumab Compared with Benralizumab in Patients with Eosinophilic Asthma: A Systematic Literature Review and Network Meta-Analysis.雷索芦单抗对比贝那利珠单抗治疗嗜酸性粒细胞性哮喘患者的疗效：系统文献回顾和网络荟萃分析。
J Allergy Clin Immunol Pract. 2019 Jan;7(1):122-130.e1. doi: 10.1016/j.jaip.2018.08.036. Epub 2018 Sep 11.
6
Pharmacokinetic/pharmacodynamic drug evaluation of benralizumab for the treatment of asthma.贝那利珠单抗治疗哮喘的药代动力学/药效学药物评价
Expert Opin Drug Metab Toxicol. 2017 Sep;13(9):1007-1013. doi: 10.1080/17425255.2017.1359253. Epub 2017 Jul 24.
7
Mepolizumab in the treatment of severe eosinophilic asthma.美泊利珠单抗治疗重度嗜酸性粒细胞性哮喘。
Immunotherapy. 2016;8(1):27-34. doi: 10.2217/imt.15.102. Epub 2015 Dec 10.
8
Targeting IL-5 in COPD.靶向 COPD 中的 IL-5。
Int J Chron Obstruct Pulmon Dis. 2019 May 16;14:1045-1051. doi: 10.2147/COPD.S155306. eCollection 2019.
9
Establishment of humanized anti-interleukin-5 receptor alpha chain monoclonal antibodies having a potent neutralizing activity.具有高效中和活性的人源化抗白细胞介素-5受体α链单克隆抗体的制备。
Hum Antibodies. 2009;18(1-2):17-27. doi: 10.3233/HAB-2009-0198.
10
Allergic diseases: From bench to clinic - Contribution of the discovery of interleukin-5.过敏性疾病：从实验室到临床——白细胞介素-5发现的贡献
Cytokine. 2017 Oct;98:59-70. doi: 10.1016/j.cyto.2016.11.011.

引用本文的文献

1
Targeted inhibition of the IL5 axis for immune checkpoint inhibitors eosinophilic-induced adverse events.针对免疫检查点抑制剂诱导的嗜酸性粒细胞不良事件中 IL5 轴的靶向抑制。
J Immunother Cancer. 2024 Oct 12;12(10):e009658. doi: 10.1136/jitc-2024-009658.
2
Novel targeted inhibition of the IL-5 axis for drug reaction with eosinophilia and systemic symptoms syndrome.新型靶向抑制白细胞介素-5 轴治疗药物反应伴嗜酸性粒细胞增多和全身性症状综合征。
Front Immunol. 2023 Apr 28;14:1134178. doi: 10.3389/fimmu.2023.1134178. eCollection 2023.
3
Eosinophilic cystitis refractory to steroids successfully treated with benralizumab: A case report.
用贝那利珠单抗成功治疗难治性嗜酸性膀胱炎：一例报告
Front Allergy. 2023 Jan 10;3:1055129. doi: 10.3389/falgy.2022.1055129. eCollection 2022.
4
Off-Label Benralizumab in Severe Non-Necrotizing Eosinophilic Vasculitis following Critical COVID-19 Disease and in DRESS.重症新型冠状病毒肺炎后严重非坏死性嗜酸性血管炎及药物超敏反应伴嗜酸性粒细胞增多综合征中使用本瑞利珠单抗的超说明书用药情况
J Clin Med. 2022 Nov 9;11(22):6642. doi: 10.3390/jcm11226642.
5
Off-Label Medication: From a Simple Concept to Complex Practical Aspects.药品未注册使用：从简单概念到复杂实际问题。
Int J Environ Res Public Health. 2021 Oct 4;18(19):10447. doi: 10.3390/ijerph181910447.